Shaken, not stirred: mechanical stress testing of an IgG1 antibody.

Protein aggregation is known to occur under different stress conditions and displays a wide variety of morphologies. In this work, the aggregation behavior of a monoclonal antibody (IgG1) was investigated using two different mechanical stress methods namely stirring and shaking at two temperatures, various fill volumes and headspaces and different amounts of polysorbate present in the formulation. The detection of aggregates in terms of size and number was carried out using various analytical techniques including visible particle inspection, turbidity, sub-visible particle analysis, size exclusion chromatography and dynamic light scattering. The data showed that shaking and stirring resulted in different species of aggregates both qualitatively and quantitatively, where stirring was found more stressful than shaking on the IgG1 formulation. Mechanical stress testing performed at 5 and 25 degrees C only showed a difference on samples stressed by shaking and not by stirring. The headspace in the vials had great influence on the stability of the protein formulation when stressed by shaking. The presence of polysorbate had a protective effect on the antibody, however certain polysorbate concentrations even resulted in increased protein aggregation. An array of analytical methods was essential in order to cover the vast aggregate morphologies, which occurred during agitation.

[1]  Chung C. Hsu,et al.  Effect of high shear on proteins , 2000, Biotechnology and bioengineering.

[2]  John P. Gabrielson,et al.  Quantitation of aggregate levels in a recombinant humanized monoclonal antibody formulation by size-exclusion chromatography, asymmetrical flow field flow fractionation, and sedimentation velocity. , 2007, Journal of pharmaceutical sciences.

[3]  Hanns-Christian Mahler,et al.  Protein aggregation: pathways, induction factors and analysis. , 2009, Journal of pharmaceutical sciences.

[4]  John F. Carpenter,et al.  Physical Stability of Proteins in Aqueous Solution: Mechanism and Driving Forces in Nonnative Protein Aggregation , 2003, Pharmaceutical Research.

[5]  Chung C. Hsu,et al.  Protein denaturation by combined effect of shear and air-liquid interface. , 1997, Biotechnology and bioengineering.

[6]  L. Bell,et al.  Effect of surfactants on the physical stability of recombinant human growth hormone. , 1995, Journal of pharmaceutical sciences.

[7]  Robert Gurny,et al.  High throughput screening of protein formulation stability: practical considerations. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[8]  Mike Hoare,et al.  Studies of the effect of shear on globular proteins: Extension to high shear fields and to pumps , 1981 .

[9]  A. Pavlou,et al.  The therapeutic antibodies market to 2008. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  C. Trägårdh,et al.  Whey protein adsorption onto steel surfaces - effect of temperature, flow rate, residence time and aggregation , 2006 .

[11]  R. Gurny,et al.  Characterization of protein aggregation: the case of a therapeutic immunoglobulin. , 2007, Biochimica et biophysica acta.

[12]  Y. J. Wang,et al.  Dual effects of Tween 80 on protein stability. , 2008, International journal of pharmaceutics.

[13]  S. Magdassi,et al.  Native and Hydrophobically Modified Human Immunoglobulin G at the Air/Water Interface. , 2001, Journal of colloid and interface science.

[14]  M. Manning,et al.  Aggregation of recombinant human interferon gamma: kinetics and structural transitions. , 1998, Journal of pharmaceutical sciences.

[15]  Henry Eyring,et al.  Conformation Changes of Proteins , 1954 .

[16]  M. Kerker Classics and classicists of colloid and interface science: 1. Michael Faraday☆ , 1986 .

[17]  R. Murphy,et al.  Misbehaving proteins : protein (mis)folding, aggregation, and stability , 2006 .

[18]  S. Charm,et al.  Shear effects on enzymes , 1981 .

[19]  Colleen E. Price,et al.  Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies. , 2008, Journal of pharmaceutical sciences.

[20]  H. Schellekens,et al.  The immunogenicity of biopharmaceuticals. Lessons learned and consequences for protein drug development. , 2003, Developments in biologicals.

[21]  B M Eckhardt,et al.  A turbidimetric method to determine visual appearance of protein solutions. , 1994, Journal of pharmaceutical science and technology : the official journal of PDA.

[22]  S. Tzannis,et al.  Adsorption of a Formulated Protein on a Drug Delivery Device Surface , 1997 .

[23]  V. Uversky A GLYmmer of insight into fibril formation. , 2005, Structure.

[24]  P Dunnill,et al.  Action of shear on enzymes: Studies with alcohol dehydrogenase , 1979, Biotechnology and bioengineering.

[25]  P. Corry,et al.  Employment of a turbidimetric assay system to measure heat-induced protein aggregation , 1992 .

[26]  M. R. Zakin,et al.  Cavitation thermometry using molecular and continuum sonoluminescence , 1996 .

[27]  M. Manning,et al.  Heterogeneous nucleation-controlled particulate formation of recombinant human platelet-activating factor acetylhydrolase in pharmaceutical formulation. , 2005, Journal of pharmaceutical sciences.

[28]  M. Kerker Classics and classicists of colloid and interface science: 6. John Tyndall , 1987 .

[29]  Wen-Yih Chen,et al.  The effects of denaturants on protein conformation and behavior at air/solution interface. , 2005, Colloids and surfaces. B, Biointerfaces.

[30]  J L Cleland,et al.  Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions. , 1998, Journal of pharmaceutical sciences.

[31]  J L Cleland,et al.  The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. , 1993, Critical reviews in therapeutic drug carrier systems.

[32]  W Wang,et al.  Instability, stabilization, and formulation of liquid protein pharmaceuticals. , 1999, International journal of pharmaceutics.

[33]  J. Philo Is any measurement method optimal for all aggregate sizes and types? , 2006, The AAPS Journal.

[34]  J. Weiss,et al.  Structural and functional changes in ultrasonicated bovine serum albumin solutions. , 2007, Ultrasonics sonochemistry.

[35]  T. L. Donaldson,et al.  Kinetics of protein denaturation at gas—liquid interfaces , 1980 .

[36]  J. Mitchell,et al.  The surface coagulation of proteins during shaking. , 1970, Journal of colloid and interface science.

[37]  Hanns-Christian Mahler,et al.  Induction and analysis of aggregates in a liquid IgG1-antibody formulation. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[38]  Wei Wang,et al.  Antibody structure, instability, and formulation. , 2007, Journal of pharmaceutical sciences.

[39]  S. Guilbert,et al.  Mechanism of heat and shear mediated aggregation of wheat gluten protein upon mixing. , 2002, Biomacromolecules.

[40]  Huub Schellekens,et al.  Factors influencing the immunogenicity of therapeutic proteins. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[41]  M C Manning,et al.  Inhibition of stress-induced aggregation of protein therapeutics. , 1999, Methods in enzymology.

[42]  A. Rosenberg,et al.  Effects of protein aggregates: An immunologic perspective , 2006, The AAPS Journal.

[43]  S. Charman,et al.  Techniques for Assessing the Effects of Pharmaceutical Excipients on the Aggregation of Porcine Growth Hormone , 1993, Pharmaceutical Research.

[44]  S. Swanson,et al.  Detection of neutralizing anti-therapeutic protein antibodies in serum or plasma samples containing high levels of the therapeutic protein. , 2006, Journal of immunological methods.

[45]  Hanns‐Christian Mahler,et al.  Behaviour of polysorbate 20 during dialysis, concentration and filtration using membrane separation techniques. , 2008, Journal of pharmaceutical sciences.

[46]  M. Manning,et al.  Effect of Tween 20 on freeze-thawing- and agitation-induced aggregation of recombinant human factor XIII. , 1998, Journal of pharmaceutical sciences.

[47]  C. Branden,et al.  Introduction to protein structure , 1991 .

[48]  S. Colombié,et al.  Lysozyme inactivation under mechanical stirring: effect of physical and molecular interfaces. , 2001, Enzyme and microbial technology.

[49]  B. Chang,et al.  Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. , 1996, Journal of pharmaceutical sciences.

[50]  T. Randolph,et al.  Stability of Protein Formulations: Investigation of Surfactant Effects by a Novel EPR Spectroscopic Technique , 2004, Pharmaceutical Research.